Back to list

Precision Neuroscience

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.
Therapeutic Devices 📍 New York, NY Founded 2021
Current Valuation
$505.12M
as of 2024-Q4
PRIVATE
Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

Company Profile

Founded
2021
HQ
New York, NY
Employees
118
Total Raised
$148.12M
Last Round
Series C — $93.12M (Oct 2024)
IPO Status
private

Fundraising Status

Series C · $93.12M · 1y 10mo ago
privateTotal raised $148.12M

Secondary Market

Implied price / share
$8.35
Last round price / share
$5.7
vs last round
+46.5%
Open interest
9
Last round price vs secondary price
Last round vs current secondary price per share$5.70Last round$8.35Current
Secondary price return by period
Secondary market period returns3-month+34.2%6-month+38.5%1-year+35.5%All-time+234%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series C$93.12MOct 2024$505.12M
MedicalNeuroscienceMedical DeviceProduct ResearchDeep Tech
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q4. Refreshed quarterly.